Finerenone for children with heart failure
Treatments studied
Part of Heart & circulation clinical trials.
This study tests a medicine called finerenone in children with heart failure. It looks at whether finerenone helps the heart work better and is safe compared to a placebo (a dummy pill), when taken with the usual heart-failure medicines.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Must be between 6 months and under 18 years old.
- Must have heart failure with a weakened heart (ejection fraction 50% or lower).
- Must have elevated NT-proBNP (a blood marker of heart failure) above a certain level.
- Must be on a stable heart-failure medicine regimen for at least 30 days.
- Must weigh at least 4 kg (about 8.8 pounds).
- Cannot have severe kidney problems or high potassium levels.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a medicine called finerenone to see if it is safe for children and young adults with heart failure when taken for a long time. It may help improve heart function and manage symptoms.
This trial tests a new medicine called finerenone to see if it can reduce heart scarring and improve heart function in people with a certain type of heart failure (preserved ejection fraction). If you qualify, you may help researchers learn if this treatment can help you feel better and stay out of the hospital.
This trial studies how safely finerenone works over 18 months in children and young adults with chronic kidney disease who also take an ACE inhibitor or ARB. It aims to better understand long-term side effects when used together with standard kidney blood-pressure medicines.
This trial tests a medication called finerenone to see if it helps people hospitalized for heart failure live longer and have fewer heart-related problems. It may be an option for those with a certain type of heart failure where the heart's pumping strength is mildly reduced or normal.
This trial tests whether finerenone can improve heart muscle thickening in patients with certain heart or kidney risk factors. It may help reduce heart strain and improve heart function.
This trial tests how safe and effective finerenone is for adults with chronic heart failure. It includes people whose heart pumps blood with at least 40% efficiency.
Hear when a new Left Ventricular Systolic Dysfunction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.